Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fishbane

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Kidney International|June 29, 2007
The new FDA label for erythropoietin treatment: how does it affect hemoglobin target?S Fishbane, A R Nissenson
Seminars in Dialysis|January 15, 2009
Current issues in iron management in end-stage renal diseaseS Fishbane, J K Maesaka
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 18, 1998
Regulation of renal urate excretion: a critical reviewJ K Maesaka, S Fishbane
Clinical Nephrology|October 1, 1995
The efficacy of iron dextran for the treatment of iron deficiency in hemodialysis patientsS Fishbane, R I Lynn
Nephron|June 12, 1999
Cerebral salt-wasting syndrome: does it exist?J K Maesaka, S Gupta, S Fishbane
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 11, 2000
Research directions: new clinical frontiersJ Lindberg, D N Churchill, S Fishbane
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 1, 1996
Role of volume overload in dialysis-refractory hypertensionS Fishbane, E Natke, J K Maesaka
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1995
Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementationS Fishbane, G L Frei, J Maesaka
Kidney International. Supplement|March 20, 1999
Beneficial effects of iron therapy in renal failure patients on hemodialysisS Fishbane, S K Mittal, J K Maesaka
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 27, 1999
Is there material hazard to treatment with intravenous iron?S Fishbane, J K Maesaka, S K Mittal
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Kidney International|June 29, 2007
The new FDA label for erythropoietin treatment: how does it affect hemoglobin target?S Fishbane, A R Nissenson
Seminars in Dialysis|January 15, 2009
Current issues in iron management in end-stage renal diseaseS Fishbane, J K Maesaka
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 18, 1998
Regulation of renal urate excretion: a critical reviewJ K Maesaka, S Fishbane
Clinical Nephrology|October 1, 1995
The efficacy of iron dextran for the treatment of iron deficiency in hemodialysis patientsS Fishbane, R I Lynn
Nephron|June 12, 1999
Cerebral salt-wasting syndrome: does it exist?J K Maesaka, S Gupta, S Fishbane
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 11, 2000
Research directions: new clinical frontiersJ Lindberg, D N Churchill, S Fishbane
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 1, 1996
Role of volume overload in dialysis-refractory hypertensionS Fishbane, E Natke, J K Maesaka
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1995
Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementationS Fishbane, G L Frei, J Maesaka
Kidney International. Supplement|March 20, 1999
Beneficial effects of iron therapy in renal failure patients on hemodialysisS Fishbane, S K Mittal, J K Maesaka
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 27, 1999
Is there material hazard to treatment with intravenous iron?S Fishbane, J K Maesaka, S K Mittal
Pageof 5